Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

被引：0
|
作者：
J. Lee
Y. H. Im
S. H. Lee
E. Y. Cho
Y. L. Choi
Y. H. Ko
J. H. Kim
S. J. Nam
H. J. Kim
J. S. Ahn
Y. S. Park
H. Y. Lim
B. K. Han
J. H. Yang
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center
[2] Sungkyunkwan University School of Medicine,Department of Pathology, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
[4] Sungkyunkwan University School of Medicine,Department of Radiology and Center for Imaging Science, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Ki-67 proliferation index; Breast cancer; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：569 / 577
页数：8
相关论文
共 50 条
  • [31] Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy
    Liebscher, Sean C.
    Kilgore, Lyndsey J.
    Winblad, Onalisa
    Gloyeske, Nika
    Larson, Kelsey
    Balanoff, Christa
    Nye, Lauren
    O'Dea, Anne
    Sharma, Priyanka
    Kimler, Bruce
    Khan, Qamar
    Wagner, Jamie
    HEALTHCARE, 2023, 11 (03)
  • [32] Prognostic Factors of Survival in Pathologic Incomplete Response Patients with Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy
    Huang, Ou
    Jiang, Min
    Chen, Xiao-Song
    Wu, Jia-Yi
    Chen, Wei-Guo
    Li, Ya-Fei
    Shen, Kun-Wei
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 1181 - 1190
  • [33] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [34] Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
    Kim, Ji-Yeon
    Oh, Jung Min
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Park, Yeon Hee
    Ahn, Jin Seok
    Kim, Kyunga
    Im, Young-Hyuck
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Tao, Miaomiao
    Chen, Shu
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2017, 96 (51)
  • [36] Changes in Ki67 expression and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer (LABC)
    Devi, Desak Gede Agung Pramesti
    Purwanto, Heru
    Sandhika, Willy
    BALI MEDICAL JOURNAL, 2021, 10 (03) : 925 - 931
  • [37] Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel
    Dede, D. S.
    Gumuskaya, B.
    Guler, G.
    Onat, D.
    Altundag, K.
    Ozisik, Y.
    JOURNAL OF BUON, 2013, 18 (01): : 57 - 63
  • [38] Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors
    Kanyilmaz, Gul
    Yavuz, Berrin Benli
    Aktan, Meryem
    Karaagac, Mustafa
    Uyar, Mehmet
    Findik, Siddika
    EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (04) : 256 - 261
  • [39] Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Fujii, Satoshi
    Wada, Noriaki
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 203 - 212
  • [40] Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer
    Nobuaki Matsubara
    Hirofumi Mukai
    Satoshi Fujii
    Noriaki Wada
    Breast Cancer Research and Treatment, 2013, 137 : 203 - 212
12345